Author Archives: Senak

Weekly Roundup 5-17-13

May 17, 2013

It has been a busy May.  From working in the yard to transform it from looking like property on which Boo Radley might have a house to putting on panel discussions and layers of business travel to grading papers and … Continue reading →

Posted in Weekly Roundup | Leave a comment

Webinar on FDA Communications Oversight in a Digital Era

May 13, 2013

Many may recall that in early April, I released a paper I did here on Eye on FDA called “FDA Communications Oversight in a Digital Era” that examined the patterns of enforcement by FDA’s Office of Prescription Drug Promotion as … Continue reading →

Posted in Warning Letters | Leave a comment

Weekly Roundup 5-3-13

May 3, 2013

The grass is not greener on my side, mainly because it is mostly not there.  The lawn, if you want to call it that, looks like it needs a lot of attention – probably more than I have to give … Continue reading →

Posted in Weekly Roundup | Comments Off

Fewer Letters, Fewer Warning Letters

May 1, 2013

It may seem that I write a lot about the letters that FDA puts out regarding industry promotion and communication, but that is exactly what the nature of this blog is about. Other things can be interesting, particularly policy developments, … Continue reading →

Posted in FDA Policy, Warning Letters | Comments Off

Weekly Roundup – 4-26-13

April 26, 2013

The spring clothes are headed to the closet, while the winter clothes are headed to their space for their seasonal slumber until next Fall.  The days are sunny. The winter mess in the yard has been cleared away (mostly) and … Continue reading →

Posted in Weekly Roundup | Comments Off